Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F De Toni… - Journal of Experimental …, 2016 - rupress.org
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
[PDF][PDF] Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F de Toni, L Gales… - J Exp Med, 2016 - academia.edu
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
[PDF][PDF] Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
FA Castelli, M Cathebas, S Zaghdoudi, L Stuani… - 2016 - researchgate.net
© 2016 Boutzen et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F de Toni… - Journal of Experimental …, 2016 - hal.science
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F de Toni… - Journal of …, 2016 - inria.hal.science
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
[PDF][PDF] Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
FA Castelli, M Cathebas, S Zaghdoudi… - J. Exp …, 2016 - pdfs.semanticscholar.org
© 2016 Boutzen et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
[HTML][HTML] Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F de Toni… - The Journal of …, 2016 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F de Toni… - Journal of …, 2016 - inserm.hal.science
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue, F De Toni, L Gales… - 2016 - agris.fao.org
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
H Boutzen, E Saland, C Larrue… - The Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …
impaired differentiation programs caused by recurrent mutations, such as the isocitrate …